Semuloparin sodium is an ultra–low molecular weight heparin (ULMWH) anticoagulant that was developed by Sanofi for prevention of venous thromboembolism but is no longer in active clinical development. The directory classifies it as a discontinued API with a biotechnology source/manufacturing origin. Other names for this substance include Visamerin and semuloparine sodique. Its PubChem SID is 481110487.
Semuloparin sodium
| CAS No | 9041-08-1 |
|---|---|
| Molecular Formula | N/A |
| Molecular Weight | 2,000–3,000 g/mol |
| Synonyms | N/A |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Semuloparin sodium is an ultra–low molecular weight heparin (ULMWH) anticoagulant that was developed by Sanofi for prevention of venous thromboembolism but is no longer in active clinical development.
The listed CAS number is 9041-08-1.
The listed molecular formula is N/A.
The listed molecular weight is 2,000–3,000 g/mol.
N/A.
The source lists Visamerin and semuloparine sodique.